In this video, IFPMA Director General Thomas Cueni explains the commitments made by the biopharmaceutical industry to step up to the coronavirus public health crisis. There is an unprecedented level of collaboration taking place across the biopharmaceutical industry as it joins with public agencies to accelerate R&D and develop solutions to coronavirus. IFPMA members are committed to work together as one team to achieve one shared goal: containing COVID-19.
• Recording of IFPMA press conference (19 March 2020) - [ Ссылка ]
• IFPMA News Release: “Industry Commitments Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health crisis” - [ Ссылка ]
• Industry Commitment: “Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis” - [ Ссылка ]
• IFPMA Backgrounder on COVID-19 - [ Ссылка ]
